Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Liposomes for effective drug delivery to the ocular posterior chamber

Fig. 4

Protection against photooxidative retinal damage. a Change of b-wave amplitude following topical administration of respective formulations for consecutive 14 days. b Fundus retinography of various formulations. c The protective efficacy evaluation of various formulations in the retina by staining hematoxylin and eosin (H&E) (scale bar = 20 μm). d Photographs of in vitro anti-ROS efficacy taken with a long-term real-time dynamic live cell imaging analyzer. e ROS level of various formulations. Data were presented as the mean ± SD (n = 3). **P < 0.01, ***P < 0.001

Back to article page